Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area apoptosis mdm2'

Search results for: 'research area apoptosis mdm2'

Items 1-10 of 57

Page
per page
  1. Nutlin-3
    A4228 Nutlin-3
    Target: MDM2
    Summary: MDM2 antagonist,inhibits MDM2-p53 interaction
      ≥58.2 mg/mL
  2. RG7112
    A3762 RG7112
     5 Citation
    Target: MDM2
    Summary: MDM2 inhibitor, first clinical
      ≥36.4 mg/mL
  3. YM155
    A4221 YM155
     2 Citation
    Target: Survivin
    Summary: Survivin suppressant,apoptosis inhibitor
      ≥22.15 mg/mL
  4. GDC-0152
    A4224 GDC-0152
     2 Citation
    Target: Inhibitor of apoptosis proteins (IAP)
    Summary: IAP antagonist,potent amd samll-molecule
      ≥24.95 mg/mL
  5. Cycloheximide
    A8244 Cycloheximide
     8 Citation
    Summary: Antibiotic,inhibitor of protein synthesis in eukaryotes
      ≥14.05 mg/mL
  6. LCL161
    A3541 LCL161
     1 Citation
    Target: Inhibitor of apoptosis proteins (IAP)
    Summary: Antagonist of IAPs inhibitor
      ≥25.05 mg/mL
  7. 2,3-DCPE hydrochloride
    A4447 2,3-DCPE hydrochloride
    Target: Apoptosis Inducers
    Summary: Bcl-XL protein expression downregulator
      <30.06 mg/mL
  8. PAC-1
    A8177 PAC-1
     1 Citation
    Target: Caspases
    Summary: Procaspase-3 activator
      insoluble in H2O; ≥13.4 mg/mL
  9. Actinomycin D
    A4448 Actinomycin D
     15 Citation
    Summary: RNA polymerase inhibitor
      ≥62.75 mg/mL
  10. NSC 687852 (b-AP15)
    A4453 NSC 687852 (b-AP15)
    Target: Deubiquitinating enzymes (DUBs)
    Summary: 19S regulatory particle Inhibitor
      insoluble in EtOH; insoluble in H2O; ≥20.95 mg/mL

Items 1-10 of 57

Page
per page
Shop By
Now Shopping by
  1. Specificity Selective Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 54item
  2. Natural Products 1 item
  3. Kits 1 item
  4. Peptides 1 item
  5. Peptides & Proteins 1 item
Reversibility
  1. Reversible 1 item
  2. Irreversible 4item
Target
  1. Caspases 9item
  2. Cyclin-Dependent Kinases 1 item
  3. Proteasome 1 item
  4. Cathepsins 1 item
  5. Histone Deacetylases (HDACs) 3item
  6. Inhibitor of apoptosis proteins (IAP) 2item
  7. Bcl-2 4item
  8. Raf 1 item
  9. Bcl-xl 2item
  10. MDM2 2item
  11. AP-1 1 item
  12. DT-diaphorases 1 item
  13. GSK-3 1 item
  14. VEGFR 2item
  15. PDGFR 1 item
  16. c-Kit 1 item
  17. RET 1 item
  18. Mcl-1 2item
  19. JNK 1 item
  20. Deubiquitinating enzymes (DUBs) 1 item
  21. Trk Receptors 1 item
  22. STAT 1 item
  23. RIP kinases 1 item
  24. JAK 2item
  25. HSP90 1 item
  26. Survivin 1 item
  27. Ubiquitin-specific proteases 1 item
  28. Melanocortin (MC) Receptors 1 item
  29. MK2 1 item
  30. Fatty-acid-binding proteins (FABPs) 1 item
  31. COX 1 item
  32. NADPH Oxidases 1 item
  33. MAGL 1 item
  34. iNOS 1 item
  35. TRP Channel 1 item
  36. Apoptosis Inducers 1 item
  37. Cdc7 1 item
  38. angiogenesis 1 item
  39. p53-MDM2 interaction 1 item
  40. PC-PLC 1 item
  41. PKD 1 item
  42. Bcl-w 1 item
Reported Experiments
  1. Animal Experiments 44item
  2. Cell Experiments 29item
Related Disease
  1. Autoimmune Diseases 1 item
  2. Breast Cancer 10item
  3. Cancer 32item
  4. Chronic Lymphocytic Leukemia 1 item
  5. Chronic Myeloproliferative Disorders 1 item
  6. Colon Cancer 5item
  7. Colon Carcinoma 1 item
  8. Colorectal Cancer 3item
  9. Glioblastoma 4item
  10. Hepatocellular Carcinoma 1 item
  11. Inflammatory Diseases 2item
  12. Leukemia 1 item
  13. Lung Cancer 2item
  14. Lymphoma 4item
  15. Melanoma 4item
  16. Multiple Myeloma 1 item
  17. Myelofibrosis 1 item
  18. Myeloma 1 item
  19. Neuroblastoma 1 item
  20. Non-small Cell Lung Cancer 2item
  21. Ovarian Cancer 1 item
  22. Pain Relief 1 item
  23. Pancreatic Cancer 3item
  24. Prostate Cancer 7item
  25. Pulmonary Fibrosis 1 item
  26. Rheumatoid Arthritis 2item
  27. Soft Tissue Sarcoma 1 item
  28. Testicular Cancer 1 item
  29. Type 2 Diabetes 2item